Medical - Healthcare Plans
Compare Stocks
2 / 10Stock Comparison
MOH vs CNC
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Healthcare Plans
MOH vs CNC — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Medical - Healthcare Plans | Medical - Healthcare Plans |
| Market Cap | $10.01B | $26.15B |
| Revenue (TTM) | $45.08B | $198.10B |
| Net Income (TTM) | $188M | $-6.44B |
| Gross Margin | 9.6% | 14.9% |
| Operating Margin | 1.2% | -3.7% |
| Forward P/E | 37.3x | 15.7x |
| Total Debt | $3.95B | $18.78B |
| Cash & Equiv. | $4.25B | $17.89B |
MOH vs CNC — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Molina Healthcare, … (MOH) | 100 | 103.4 | +3.4% |
| Centene Corporation (CNC) | 100 | 79.9 | -20.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: MOH vs CNC
Each card shows where this stock fits in a portfolio — not just who wins on paper.
MOH is the clearest fit if your priority is growth exposure and long-term compounding.
- Rev growth 11.7%, EPS growth -56.3%, 3Y rev CAGR 12.4%
- 323.6% 10Y total return vs CNC's 74.6%
- Lower volatility, beta -0.04, Low D/E 97.1%, current ratio 1.69x
CNC carries the broadest edge in this set and is the clearest fit for growth and value.
- 19.4% revenue growth vs MOH's 11.7%
- Lower P/E (15.7x vs 37.3x)
- Lower D/E ratio (93.6% vs 97.1%)
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 19.4% revenue growth vs MOH's 11.7% | |
| Value | Lower P/E (15.7x vs 37.3x) | |
| Quality / Margins | Combined ratio 1.0 vs CNC's 1.0 (lower = better underwriting) | |
| Stability / Safety | Lower D/E ratio (93.6% vs 97.1%) | |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | -11.4% vs MOH's -39.9% | |
| Efficiency (ROA) | 1.2% ROA vs CNC's -7.9%, ROIC 17.4% vs -21.6% |
MOH vs CNC — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
MOH vs CNC — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
CNC leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
CNC is the larger business by revenue, generating $198.1B annually — 4.4x MOH's $45.1B. Profitability is closely matched — net margins range from 0.4% (MOH) to -3.3% (CNC). On growth, CNC holds the edge at +7.1% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $45.1B | $198.1B |
| EBITDAEarnings before interest/tax | $710M | -$5.9B |
| Net IncomeAfter-tax profit | $188M | -$6.4B |
| Free Cash FlowCash after capex | $251M | $6.3B |
| Gross MarginGross profit ÷ Revenue | +9.6% | +14.9% |
| Operating MarginEBIT ÷ Revenue | +1.2% | -3.7% |
| Net MarginNet income ÷ Revenue | +0.4% | -3.3% |
| FCF MarginFCF ÷ Revenue | +0.6% | +3.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | -3.1% | +7.1% |
| EPS Growth (YoY)Latest quarter vs prior year | -95.0% | +18.3% |
Valuation Metrics
CNC leads this category, winning 4 of 4 comparable metrics.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $10.0B | $26.2B |
| Enterprise ValueMkt cap + debt − cash | $9.7B | $27.0B |
| Trailing P/EPrice ÷ TTM EPS | 21.54x | -3.89x |
| Forward P/EPrice ÷ next-FY EPS est. | 37.27x | 15.70x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | 9.95x | — |
| Price / SalesMarket cap ÷ Revenue | 0.22x | 0.13x |
| Price / BookPrice ÷ Book value/share | 2.40x | 1.30x |
| Price / FCFMarket cap ÷ FCF | — | 6.05x |
Profitability & Efficiency
MOH leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
MOH delivers a 4.4% return on equity — every $100 of shareholder capital generates $4 in annual profit, vs $-29 for CNC. CNC carries lower financial leverage with a 0.94x debt-to-equity ratio, signaling a more conservative balance sheet compared to MOH's 0.97x. On the Piotroski fundamental quality scale (0–9), CNC scores 6/9 vs MOH's 4/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +4.4% | -28.6% |
| ROA (TTM)Return on assets | +1.2% | -7.9% |
| ROICReturn on invested capital | +17.4% | -21.6% |
| ROCEReturn on capital employed | +9.8% | -14.6% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 6 |
| Debt / EquityFinancial leverage | 0.97x | 0.94x |
| Net DebtTotal debt minus cash | -$298M | $889M |
| Cash & Equiv.Liquid assets | $4.2B | $17.9B |
| Total DebtShort + long-term debt | $4.0B | $18.8B |
| Interest CoverageEBIT ÷ Interest expense | 2.12x | -9.03x |
Total Returns (Dividends Reinvested)
CNC leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CNC five years ago would be worth $8,112 today (with dividends reinvested), compared to $7,307 for MOH. Over the past 12 months, CNC leads with a -11.4% total return vs MOH's -39.9%. The 3-year compound annual growth rate (CAGR) favors CNC at -8.2% vs MOH's -13.8% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +7.7% | +26.8% |
| 1-Year ReturnPast 12 months | -39.9% | -11.4% |
| 3-Year ReturnCumulative with dividends | -35.8% | -22.6% |
| 5-Year ReturnCumulative with dividends | -26.9% | -18.9% |
| 10-Year ReturnCumulative with dividends | +323.6% | +74.6% |
| CAGR (3Y)Annualised 3-year return | -13.8% | -8.2% |
Risk & Volatility
Evenly matched — MOH and CNC each lead in 1 of 2 comparable metrics.
Risk & Volatility
MOH is the less volatile stock with a -0.04 beta — it tends to amplify market swings less than CNC's 0.39 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CNC currently trades 82.6% from its 52-week high vs MOH's 57.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | -0.04x | 0.39x |
| 52-Week HighHighest price in past year | $333.00 | $64.15 |
| 52-Week LowLowest price in past year | $121.06 | $25.08 |
| % of 52W HighCurrent price vs 52-week peak | +57.7% | +82.6% |
| RSI (14)Momentum oscillator 0–100 | 79.6 | 83.9 |
| Avg Volume (50D)Average daily shares traded | 1.4M | 5.7M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Wall Street rates MOH as "Buy" and CNC as "Buy". Consensus price targets imply -3.7% upside for CNC (target: $51) vs -13.6% for MOH (target: $166).
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $166.09 | $51.00 |
| # AnalystsCovering analysts | 38 | 43 |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | — | 1 |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +10.0% | +1.8% |
CNC leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). MOH leads in 1 (Profitability & Efficiency). 1 tied.
MOH vs CNC: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is MOH or CNC a better buy right now?
For growth investors, Centene Corporation (CNC) is the stronger pick with 19.
4% revenue growth year-over-year, versus 11. 7% for Molina Healthcare, Inc. (MOH). Molina Healthcare, Inc. (MOH) offers the better valuation at 21. 5x trailing P/E (37. 3x forward), making it the more compelling value choice. Analysts rate Molina Healthcare, Inc. (MOH) a "Buy" — based on 38 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — MOH or CNC?
On forward P/E, Centene Corporation is actually cheaper at 15.
7x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — MOH or CNC?
Over the past 5 years, Centene Corporation (CNC) delivered a total return of -18.
9%, compared to -26. 9% for Molina Healthcare, Inc. (MOH). Over 10 years, the gap is even starker: MOH returned +323. 6% versus CNC's +74. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — MOH or CNC?
By beta (market sensitivity over 5 years), Molina Healthcare, Inc.
(MOH) is the lower-risk stock at -0. 04β versus Centene Corporation's 0. 39β — meaning CNC is approximately -1170% more volatile than MOH relative to the S&P 500. On balance sheet safety, Centene Corporation (CNC) carries a lower debt/equity ratio of 94% versus 97% for Molina Healthcare, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — MOH or CNC?
By revenue growth (latest reported year), Centene Corporation (CNC) is pulling ahead at 19.
4% versus 11. 7% for Molina Healthcare, Inc. (MOH). On earnings-per-share growth, the picture is similar: Molina Healthcare, Inc. grew EPS -56. 3% year-over-year, compared to -315. 8% for Centene Corporation. Over a 3-year CAGR, MOH leads at 12. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — MOH or CNC?
Molina Healthcare, Inc.
(MOH) is the more profitable company, earning 1. 0% net margin versus -3. 4% for Centene Corporation — meaning it keeps 1. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MOH leads at 1. 7% versus -3. 9% for CNC. At the gross margin level — before operating expenses — CNC leads at 12. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is MOH or CNC more undervalued right now?
On forward earnings alone, Centene Corporation (CNC) trades at 15.
7x forward P/E versus 37. 3x for Molina Healthcare, Inc. — 21. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CNC: -3. 7% to $51. 00.
08Which pays a better dividend — MOH or CNC?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
09Is MOH or CNC better for a retirement portfolio?
For long-horizon retirement investors, Molina Healthcare, Inc.
(MOH) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 04), +323. 6% 10Y return). Both have compounded well over 10 years (MOH: +323. 6%, CNC: +74. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between MOH and CNC?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: MOH is a mid-cap quality compounder stock; CNC is a mid-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.